Research Paper Volume 16, Issue 5 pp 4423—4444
SLC20A1 is a prospective prognostic and therapy response predictive biomarker in head and neck squamous cell carcinoma
Figure 6. Chemotherapy and immunotherapy response were associated with SLC20A1 expression in HNSCC. (A) Chemotherapeutic responses with differential SLC20A1 expression in HNSCC. (B) Correlation between SLC20A1 expression and immunotherapy responses. *, P<0.05. **, P<0.01. ***, P<0.001. IC50, 50% inhibiting concentration.